{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:20:58Z","timestamp":1792790458431,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2021-122116OB-I00"],"award-info":[{"award-number":["PID2021-122116OB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2021-122116OB-I00"],"award-info":[{"award-number":["PID2021-122116OB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-024-01972-5","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T15:44:52Z","timestamp":1734536692000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["PPAR\u03b2\/\u03b4 upregulates the insulin receptor \u03b2 subunit in skeletal muscle by reducing lysosomal activity and EphB4 levels"],"prefix":"10.1186","volume":"22","author":[{"given":"Jue-Rui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Jurado-Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Barroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Rodr\u00edguez-Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Camins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Wahli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Palomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"V\u00e1zquez-Carrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"1972_CR1","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1007\/s00125-021-05415-5","volume":"64","author":"TM Batista","year":"2021","unstructured":"Batista TM, et al. Defining the underlying defect in insulin action in type 2 diabetes. Diabetologia. 2021;64:994\u20131006. https:\/\/doi.org\/10.1007\/s00125-021-05415-5.","journal-title":"Diabetologia"},{"issue":"Suppl 2","key":"1972_CR2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2337\/dc09-S302","volume":"32","author":"RA DeFronzo","year":"2009","unstructured":"DeFronzo RA, Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care. 2009;32(Suppl 2):157\u201363. https:\/\/doi.org\/10.2337\/dc09-S302.","journal-title":"Diabetes Care"},{"key":"1972_CR3","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/j.1600-0854.2011.01178.x","volume":"12","author":"AF Rowland","year":"2011","unstructured":"Rowland AF, et al. Mapping insulin\/GLUT4 circuitry. Traffic. 2011;12:672\u201381. https:\/\/doi.org\/10.1111\/j.1600-0854.2011.01178.x.","journal-title":"Traffic"},{"key":"1972_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.bbadis.2008.10.019","volume":"1792","author":"S Frojdo","year":"2009","unstructured":"Frojdo S, et al. Alterations of insulin signaling in type 2 diabetes: a review of the current evidence from humans. Biochim Biophys Acta. 2009;1792:83\u201392. https:\/\/doi.org\/10.1016\/j.bbadis.2008.10.019.","journal-title":"Biochim Biophys Acta"},{"key":"1972_CR5","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1007\/s00125-017-4394-0","volume":"60","author":"AC Lay","year":"2017","unstructured":"Lay AC, et al. Prolonged exposure of mouse and human podocytes to insulin induces insulin resistance through lysosomal and proteasomal degradation of the insulin receptor. Diabetologia. 2017;60:2299\u2013311. https:\/\/doi.org\/10.1007\/s00125-017-4394-0.","journal-title":"Diabetologia"},{"key":"1972_CR6","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1124\/mol.109.057067","volume":"76","author":"L Zhou","year":"2009","unstructured":"Zhou L, et al. Autophagy-mediated insulin receptor down-regulation contributes to endoplasmic reticulum stress-induced insulin resistance. Mol Pharmacol. 2009;76:596\u2013603. https:\/\/doi.org\/10.1124\/mol.109.057067.","journal-title":"Mol Pharmacol"},{"key":"1972_CR7","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1091\/mbc.E18-01-0013","volume":"31","author":"M Brown","year":"2020","unstructured":"Brown M, et al. Endoplasmic reticulum stress causes insulin resistance by inhibiting delivery of newly synthesized insulin receptors to the cell surface. Mol Biol Cell. 2020;31:2597\u2013629. https:\/\/doi.org\/10.1091\/mbc.E18-01-0013.","journal-title":"Mol Biol Cell"},{"key":"1972_CR8","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/s42255-022-00634-5","volume":"4","author":"X Liu","year":"2022","unstructured":"Liu X, et al. Insulin induces insulin receptor degradation in the liver through EphB4. Nat Metab. 2022;4:1202\u201313. https:\/\/doi.org\/10.1038\/s42255-022-00634-5.","journal-title":"Nat Metab"},{"key":"1972_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.tem.2016.02.008","volume":"27","author":"M Vazquez-Carrera","year":"2016","unstructured":"Vazquez-Carrera M. Unraveling the effects of PPARbeta\/delta on insulin resistance and Cardiovascular Disease. Trends Endocrinol Metab. 2016;27:319\u201334. https:\/\/doi.org\/10.1016\/j.tem.2016.02.008.","journal-title":"Trends Endocrinol Metab"},{"key":"1972_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.cmet.2006.10.003","volume":"4","author":"M Schuler","year":"2006","unstructured":"Schuler M, et al. PGC1alpha expression is controlled in skeletal muscles by PPARbeta, whose ablation results in fiber-type switching, obesity, and type 2 diabetes. Cell Metab. 2006;4:407\u201314. https:\/\/doi.org\/10.1016\/j.cmet.2006.10.003.","journal-title":"Cell Metab"},{"key":"1972_CR11","doi-asserted-by":"publisher","first-page":"109501","DOI":"10.1016\/j.celrep.2021.109501","volume":"36","author":"D Aguilar-Recarte","year":"2021","unstructured":"Aguilar-Recarte D, et al. GDF15 mediates the metabolic effects of PPARbeta\/delta by activating AMPK. Cell Rep. 2021;36:109501. https:\/\/doi.org\/10.1016\/j.celrep.2021.109501.","journal-title":"Cell Rep"},{"key":"1972_CR12","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.bbrc.2019.02.013","volume":"510","author":"WJ Kim","year":"2019","unstructured":"Kim WJ, et al. PPARbeta\/delta agonist GW501516 inhibits TNFalpha-induced repression of adiponectin and insulin receptor in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2019;510:621\u20138. https:\/\/doi.org\/10.1016\/j.bbrc.2019.02.013.","journal-title":"Biochem Biophys Res Commun"},{"key":"1972_CR13","doi-asserted-by":"publisher","unstructured":"Montori-Grau M, et al. Endoplasmic reticulum stress downregulates PGC-1alpha in skeletal muscle through ATF4 and an mTOR-mediated reduction of CRTC2. Cell Commun Signal. 2022;20. https:\/\/doi.org\/10.1186\/s12964-022-00865-9.","DOI":"10.1186\/s12964-022-00865-9"},{"key":"1972_CR14","doi-asserted-by":"publisher","first-page":"15924","DOI":"10.1073\/pnas.0306981100","volume":"100","author":"T Tanaka","year":"2003","unstructured":"Tanaka T, et al. Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci U S A. 2003;100:15924\u20139. https:\/\/doi.org\/10.1073\/pnas.0306981100.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1972_CR15","doi-asserted-by":"publisher","first-page":"117303","DOI":"10.1016\/j.biopha.2024.117303","volume":"179","author":"M Zhang","year":"2024","unstructured":"Zhang M, et al. PPARbeta\/delta attenuates hepatic fibrosis by reducing SMAD3 phosphorylation and p300 levels via AMPK in hepatic stellate cells. Biomed Pharmacother. 2024;179:117303. https:\/\/doi.org\/10.1016\/j.biopha.2024.117303.","journal-title":"Biomed Pharmacother"},{"key":"1972_CR16","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1080\/15548627.2018.1474314","volume":"14","author":"M Mauthe","year":"2018","unstructured":"Mauthe M, et al. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy. 2018;14:1435\u201355. https:\/\/doi.org\/10.1080\/15548627.2018.1474314.","journal-title":"Autophagy"},{"key":"1972_CR17","doi-asserted-by":"publisher","first-page":"155772","DOI":"10.1016\/j.metabol.2023.155772","volume":"152","author":"J Jurado-Aguilar","year":"2024","unstructured":"Jurado-Aguilar J, et al. GDF15 activates AMPK and inhibits gluconeogenesis and fibrosis in the liver by attenuating the TGF-beta1\/SMAD3 pathway. Metabolism. 2024;152:155772. https:\/\/doi.org\/10.1016\/j.metabol.2023.155772.","journal-title":"Metabolism"},{"key":"1972_CR18","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.bbadis.2015.02.010","volume":"1852","author":"E Barroso","year":"2015","unstructured":"Barroso E, et al. PPARbeta\/delta ameliorates fructose-induced insulin resistance in adipocytes by preventing Nrf2 activation. Biochim Biophys Acta. 2015;1852:1049\u201358. https:\/\/doi.org\/10.1016\/j.bbadis.2015.02.010.","journal-title":"Biochim Biophys Acta"},{"key":"1972_CR19","doi-asserted-by":"publisher","unstructured":"Di Francesco A, et al. NQO1 protects obese mice through improvements in glucose and lipid metabolism. NPJ Aging Mech Dis. 2020;6. https:\/\/doi.org\/10.1038\/s41514-020-00051-6.","DOI":"10.1038\/s41514-020-00051-6"},{"key":"1972_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41419-023-05873-2","volume":"14","author":"L Dong","year":"2023","unstructured":"Dong L, et al. SMURF1 attenuates endoplasmic reticulum stress by promoting the degradation of KEAP1 to activate NRF2 antioxidant pathway. Cell Death Dis. 2023;14:361. https:\/\/doi.org\/10.1038\/s41419-023-05873-2.","journal-title":"Cell Death Dis"},{"key":"1972_CR21","doi-asserted-by":"publisher","first-page":"4800","DOI":"10.1111\/jcmm.16452","volume":"25","author":"N Moruzzi","year":"2021","unstructured":"Moruzzi N, et al. Tissue-specific expression of insulin receptor isoforms in obesity\/type 2 diabetes mouse models. J Cell Mol Med. 2021;25:4800\u201313. https:\/\/doi.org\/10.1111\/jcmm.16452.","journal-title":"J Cell Mol Med"},{"key":"1972_CR22","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.18632\/oncotarget.27645","volume":"11","author":"R Sarfstein","year":"2020","unstructured":"Sarfstein R, Werner H. Tumor suppressor p53 regulates insulin receptor (INSR) gene expression via direct binding to the INSR promoter. Oncotarget. 2020;11:2424\u201337. https:\/\/doi.org\/10.18632\/oncotarget.27645.","journal-title":"Oncotarget"},{"key":"1972_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/ncb0310-207","volume":"12","author":"TE Rusten","year":"2010","unstructured":"Rusten TE, Stenmark H. p62, an autophagy hero or culprit? Nat Cell Biol. 2010;12:207\u20139. https:\/\/doi.org\/10.1038\/ncb0310-207.","journal-title":"Nat Cell Biol"},{"key":"1972_CR24","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1007\/s00125-014-3331-8","volume":"57","author":"L Salvado","year":"2014","unstructured":"Salvado L, et al. PPARbeta\/delta prevents endoplasmic reticulum stress-associated inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism. Diabetologia. 2014;57:2126\u201335. https:\/\/doi.org\/10.1007\/s00125-014-3331-8.","journal-title":"Diabetologia"},{"key":"1972_CR25","doi-asserted-by":"publisher","first-page":"4685","DOI":"10.1038\/onc.2013.413","volume":"33","author":"A Sparks","year":"2014","unstructured":"Sparks A, et al. The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a. Oncogene. 2014;33:4685\u201396. https:\/\/doi.org\/10.1038\/onc.2013.413.","journal-title":"Oncogene"},{"key":"1972_CR26","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.tem.2015.05.007","volume":"26","author":"L Salvado","year":"2015","unstructured":"Salvado L, et al. Targeting endoplasmic reticulum stress in insulin resistance. Trends Endocrinol Metab. 2015;26:438\u201348. https:\/\/doi.org\/10.1016\/j.tem.2015.05.007.","journal-title":"Trends Endocrinol Metab"},{"key":"1972_CR27","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1126\/science.1103160","volume":"306","author":"U Ozcan","year":"2004","unstructured":"Ozcan U, et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science. 2004;306:457\u201361. https:\/\/doi.org\/10.1126\/science.1103160.","journal-title":"Science"},{"key":"1972_CR28","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.2337\/db08-0604","volume":"57","author":"G Boden","year":"2008","unstructured":"Boden G, et al. Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals. Diabetes. 2008;57:2438\u201344. https:\/\/doi.org\/10.2337\/db08-0604.","journal-title":"Diabetes"},{"key":"1972_CR29","doi-asserted-by":"publisher","first-page":"680","DOI":"10.2337\/diab.26.7.680","volume":"26","author":"JM Olefsky","year":"1977","unstructured":"Olefsky JM, Reaven GM. Insulin binding in diabetes. Relationships with plasma insulin levels and insulin sensitivity. Diabetes. 1977;26:680\u20138. https:\/\/doi.org\/10.2337\/diab.26.7.680.","journal-title":"Diabetes"},{"key":"1972_CR30","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1172\/jci110350","volume":"68","author":"OG Kolterman","year":"1981","unstructured":"Kolterman OG, et al. Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. J Clin Invest. 1981;68:957\u201369. https:\/\/doi.org\/10.1172\/jci110350.","journal-title":"J Clin Invest"},{"key":"1972_CR31","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1172\/JCI109790","volume":"65","author":"OG Kolterman","year":"1980","unstructured":"Kolterman OG, et al. Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects. J Clin Invest. 1980;65:1272\u201384. https:\/\/doi.org\/10.1172\/JCI109790.","journal-title":"J Clin Invest"},{"key":"1972_CR32","doi-asserted-by":"publisher","first-page":"e64436","DOI":"10.1371\/journal.pone.0064436","volume":"8","author":"LV Fedorova","year":"2013","unstructured":"Fedorova LV, et al. Peroxisome proliferator-activated receptor delta agonist, HPP593, prevents renal necrosis under chronic ischemia. PLoS ONE. 2013;8:e64436. https:\/\/doi.org\/10.1371\/journal.pone.0064436.","journal-title":"PLoS ONE"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01972-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-024-01972-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01972-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T16:10:12Z","timestamp":1734538212000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-024-01972-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1972"],"URL":"https:\/\/doi.org\/10.1186\/s12964-024-01972-5","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"22 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"595"}}